Pharmazz Inc. Raises $25Million Strategic Equity from Sun Pharma
June 11, 2025
Funding supports pivotal Phase 3 trial for sovateltide, a potential first-in-class therapy that could transform the treatment of acute cerebral ischemic stroke Pharmazz , a